# PDS Biotechnology Corporation (PDSB) · Edgar & Edgarette company card

> Figures from the company's own SEC filings.

SEC CIK 1472091 · fiscal year ended — · 0 audited years read · [page](https://www.pops4.com/boards/company/PDSB) · [JSON](https://www.pops4.com/boards/company/PDSB.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | — |
| Revenue growth, 1 year | — |
| Revenue growth per year | — |
| Operating margin | — |
| Net margin | — |
| Operating cash flow | — |
| Capital spending | — |
| Free cash flow | — |
| Cash | — |
| Long-term debt | — |
| Total assets | — |
| Total equity | — |
| Equity ÷ assets | — |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures


## Edgarette's reading

The filings carry no annual revenue line Edgarette can read (common for banks and insurers, which report income differently). Nothing weighed, nothing guessed.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 2, latest 2026-07-31 ([filing](https://www.sec.gov/Archives/edgar/data/1472091/000114036126030497/0001140361-26-030497-index.htm))
- Item 2.05 Restructuring or exit costs: 1, latest 2026-08-25 ([filing](https://www.sec.gov/Archives/edgar/data/1472091/000114036126034320/0001140361-26-034320-index.htm))
- Item 5.02 Director or officer change: 4, latest 2026-10-20 ([filing](https://www.sec.gov/Archives/edgar/data/1472091/000114036126040181/0001140361-26-040181-index.htm))

## Recent filings

- 8-K · filed 2026-10-21 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1472091/000114036126040283/0001140361-26-040283-index.htm)
- 8-K · filed 2026-10-20 · 5.02 Departure or Election of Directors; Appointment of Officers; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1472091/000114036126040181/0001140361-26-040181-index.htm)
- 8-K · filed 2026-10-06 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1472091/000114036126038728/0001140361-26-038728-index.htm)
- 8-K · filed 2026-09-22 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1472091/000114036126037298/0001140361-26-037298-index.htm)
- 8-K · filed 2026-09-21 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1472091/000114036126037234/0001140361-26-037234-index.htm)
- 8-K · filed 2026-09-14 · 1.02 Termination of a Material Definitive Agreement; 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1472091/000114036126036489/0001140361-26-036489-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001472091.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1472091

## Cite

POPS4, Edgar & Edgarette: PDS Biotechnology Corporation (PDSB) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/PDSB. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.